BioSpace News Archive

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following investor conferences:

Invacare Corporation (NYSE: IVC) today announced that it has entered into a cooperation agreement with its largest shareholder, Azurite Management LLC (“Azurite”), which currently owns approximately 10.3% of the company’s outstanding shares as of June 30, 2022.

AiM Medical Robotics, today announced the unveiling of a prototype of its industry-first robotics platform as well as the receipt of funding from the Sontag Innovation Fund, a wholly-owned venture subsidiary of The Sontag Foundation, one of the largest private funders of brain cancer research in the United States.

Astex Pharmaceuticals, Inc. announce that the European Medicines Agency has accepted the Marketing Authorisation Application for the oral fixed-dose combination of decitabine and cedazuridine for the initial treatment of adults with acute myeloid leukemia who are not candidates for standard induction chemotherapy.

RELIEF THERAPEUTICS and NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) (" NRx "), today announced that they have agreed to a tentative settlement of their pending litigation.

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has entered into a definitive agreement to acquire Standard Bariatrics, Inc. which has commercialized an innovative powered stapling technology for bariatric surgery.

Attralus, Inc. today announced that new data across the Company’s amyloidosis portfolio will be presented in both oral and poster presentations at the XVIII International Symposium on Amyloidosis (ISA) by Attralus, the University of Tennessee Graduate School of Medicine and the Brigham and Women’s Hospital.

Travere Therapeutics, Inc. (NASDAQ: TVTX) and CSL Vifor today announced that the EMA has accepted for review the Conditional Marketing Authorization (CMA) application for sparsentan for the treatment of Nephropathy.

WebPT, the leading rehab therapy platform for enhancing patient care and fueling business growth, today announces the release of the Keet Remote Therapeutic Monitoring (RTM) Dashboard and enhanced integrations with the WebPT and Insight EMRs.

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) has transferred common shares in an amount equal to approximately 38.6% of the issued and outstanding shares of Bausch + Lomb Corporation (“Bausch + Lomb”) to an existing wholly-owned unrestricted subsidiary of the Company (the “Internal Transfer”).